homocysteine has been researched along with No-Reflow Phenomenon in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, F; Li, HD; Wang, BB; Yu, H; Zhao, M | 1 |
| Qin, F; Tang, O; Wu, J | 1 |
| Çamsarı, A; Ciçek, D; Özcan, IT; Seyis, AS; Yurtdaş, M | 1 |
1 review(s) available for homocysteine and No-Reflow Phenomenon
| Article | Year |
|---|---|
Homocysteine levels in patients with coronary slow flow phenomenon: A meta-analysis.
Topics: Coronary Angiography; Homocysteine; Humans; Myocardial Infarction; No-Reflow Phenomenon | 2023 |
2 other study(ies) available for homocysteine and No-Reflow Phenomenon
| Article | Year |
|---|---|
Relationship between methylenetetrahydrofolate reductase gene polymorphism and the coronary slow flow phenomenon.
Topics: Aged; Biomarkers; Case-Control Studies; Chi-Square Distribution; Coronary Angiography; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Homocysteine; Humans; Linear Models; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; No-Reflow Phenomenon; Phenotype; Polymorphism, Genetic; Risk Factors; Sex Factors | 2014 |
Plasma homocysteine is associated with ischemic findings without organic stenosis in patients with slow coronary flow.
Topics: Adult; Angina Pectoris; Biomarkers; Blood Flow Velocity; Case-Control Studies; Coronary Circulation; Electrocardiography; Exercise Test; Female; Homocysteine; Humans; Ischemia; Male; Middle Aged; No-Reflow Phenomenon | 2013 |